Halda Therapeutics

Halda Therapeutics is a biotechnology company focused on developing novel cancer therapies. Their unique approach involves RIPTAC™ therapeutics, a class of precision medicines designed to "hold and kill" cancer cells. RIPTAC therapeutics target two proteins within the cancer cell: a tumor-specific protein and a protein with an essential function. By binding these proteins together, RIPTAC disrupts the essential protein's function and selectively kills the cancer cell. This innovative mechanism aims to overcome common drug resistance, a significant challenge in current cancer treatments.

Halda has built a strong platform and pipeline, with lead programs focused on prostate and breast cancer, two prevalent solid tumor types. The company has secured significant funding and is progressing towards clinical trials for their RIPTAC candidates. They are committed to developing oral, selective, and widely applicable cancer cell-killing mechanisms that can address unmet needs in the oncology field. Halda's mission is to envision a future where cancer is curable and to pioneer new medicines for cancer patients.

Halda Therapeutics offers an active internship program and encourages employees to bring their real selves to the workplace, fostering a collaborative environment where individuals can grow and contribute to their collective goals. The company’s commitment to employee development and a culture of inclusion suggests a flexible and supportive work environment, although specific details about remote work options, work-life balance policies, or flexible schedules are not explicitly mentioned.

Halda Therapeutics is a biotechnology company developing a novel class of cancer therapies called RIPTAC™ therapeutics. RIPTAC therapeutics are heterobifunctional small molecules that work by a "hold and kill" mechanism, targeting and selectively killing cancer cells by holding two proteins together: one that is tumor-specific and another that performs an essential function. The company's mission is to overcome the limitations of today's precision oncology medicines, such as drug resistance, and provide innovative, oral, and widely applicable cancer cell-killing mechanisms for patients with major solid tumors.

Halda Therapeutics fosters a collaborative and innovative work environment where employees feel empowered to grow and contribute to their shared mission of conquering cancer. The company values individual contributions and encourages a spirit of audaciousness, allowing employees to bring their authentic selves to work and pursue their passions.

Halda Therapeutics values diversity and inclusion as integral to its success. The company actively encourages a culture where every individual can bring their unique perspective and talents to contribute to the team's collective goal of developing life-saving medicines. Halda has partnered with organizations like Humanity Talent Network and Executive Women in Bio to further its commitment to diversity and inclusion, creating a supportive and welcoming environment for all team members.